- Home
- ORKA vs VEL Comparison
ORKA vs VEL Comparison
Compare ORKA & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- VEL
- Stock Information
- Founded
- ORKA 2004
- VEL 2004
- Country
- ORKA United States
- VEL United States
- Employees
- ORKA N/A
- VEL N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VEL Finance: Consumer Services
- Sector
- ORKA Health Care
- VEL Finance
- Exchange
- ORKA Nasdaq
- VEL Nasdaq
- Market Cap
- ORKA 580.3M
- VEL 602.1M
- IPO Year
- ORKA N/A
- VEL 2020
- Fundamental
- Price
- ORKA $20.43
- VEL $18.06
- Analyst Decision
- ORKA Strong Buy
- VEL Strong Buy
- Analyst Count
- ORKA 7
- VEL 3
- Target Price
- ORKA $43.00
- VEL $21.67
- AVG Volume (30 Days)
- ORKA 520.4K
- VEL 103.8K
- Earning Date
- ORKA 11-12-2025
- VEL 11-06-2025
- Dividend Yield
- ORKA N/A
- VEL N/A
- EPS Growth
- ORKA N/A
- VEL 26.95
- EPS
- ORKA N/A
- VEL 2.22
- Revenue
- ORKA N/A
- VEL $195,592,000.00
- Revenue This Year
- ORKA N/A
- VEL $3.99
- Revenue Next Year
- ORKA N/A
- VEL $29.69
- P/E Ratio
- ORKA N/A
- VEL $8.14
- Revenue Growth
- ORKA N/A
- VEL 44.29
- 52 Week Low
- ORKA $5.49
- VEL $16.12
- 52 Week High
- ORKA $31.13
- VEL $20.98
- Technical
- Relative Strength Index (RSI)
- ORKA 68.72
- VEL 41.33
- Support Level
- ORKA $18.19
- VEL $17.80
- Resistance Level
- ORKA $21.18
- VEL $18.34
- Average True Range (ATR)
- ORKA 1.42
- VEL 0.37
- MACD
- ORKA 0.41
- VEL -0.07
- Stochastic Oscillator
- ORKA 89.03
- VEL 19.07
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.